Status:
COMPLETED
Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"
Lead Sponsor:
Aziende Chimiche Riunite Angelini Francesco S.p.A
Conditions:
Schizophrenia
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is observation, in an Italian real-world setting, of metabolic effects in patients with schizophrenia who will switch from any mono-therapy or poly-therapy antipsychotic regimen ...
Detailed Description
The aim of this study is the observation, in psychiatric Italian real-world settings, of metabolic effects, effectiveness, side effects and therapeutic adherence in patients with schizophrenia who swi...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of schizophrenia according to DSM-5.
- Patients who gave their written consent for participation in the study and for personal data processing and willing to comply with all study procedures.
- Male and female patients ≥ of 18 years old at baseline.
- Patients treated or in treatment with any typical or atypical antipsychotic monotherapy or polytherapy.
- Patients switched from the pre-existing therapy to lurasidone, aripiprazole, olanzapine, quetiapine or risperidone in monotherapy within the preceding 2 weeks. The date of the switch is considered as baseline.
Exclusion
- Female patients who are pregnant or lactating
- Patients fulfilling DSM-5 criteria for diagnosis of bipolar disorder and/or dementia.
- Amphetamines and/or Opiates abuse or dependence , as defined by DSM-5 criteria.
- Patients with no history of antipsychotics use.
- Patients recruited in another study as follows:
- currently enrolled in any pharmacological or non-pharmacological, interventional or observational study:
- who participated in the last 30 days to any observational or no-profit interventional study;
- who participated in the last 12 months to any interventional commercially sponsored study.
Key Trial Info
Start Date :
July 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2022
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT04312503
Start Date
July 13 2020
End Date
October 31 2022
Last Update
May 6 2023
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedali Riuniti SOD di Clinica Psichiatrica
Ancona, AN, Italy, 60126
2
Spedali Civili di Brescia Dipartimento di Salute Mentale 1
Brescia, BS, Italy, 25123
3
A.O.U. di Cagliari Corso Vittorio Emanuele II, 6 09124 Cagliari (CA)
Cagliari, CA, Italy, 09124
4
P.O. Gaspare Rodolico - U.O.C. di Psichiatria
Catania, CT, Italy, 95125